Related Subjects:
|Subarachnoid Haemorrhage
|Haemorrhagic stroke
🌫️ Moyamoya disease is a progressive, non-inflammatory vasculopathy affecting the intracranial internal carotid arteries (ICA), middle cerebral arteries (MCA), and anterior cerebral arteries (ACA).
It causes both ischaemic and haemorrhagic stroke.
On angiography, a hazy network of collateral vessels forms, resembling "moyamoya" — the Japanese word for smoke drifting in the air.
First described in 1957, the name was popularised by Jiro Suzuki in 1965 and later codified [Suzuki J, 1983].
📖 About
- Described in Japan in 1957 as “hypoplasia of the bilateral ICAs”; renamed “Moyamoya” in 1965.
- 🧮 Incidence: ~10/100,000 in Japan; ~1/1,000,000 in the USA.
- Involves progressive ICA occlusion and development of fragile collateral vessels.
- Increased basic fibroblast growth factor has been implicated in pathogenesis.
- Can be sporadic or familial, leading to both ischaemic and haemorrhagic stroke.
🧬 Genetics
- Most common in Japanese, Chinese, and Korean populations (10x more frequent than in Europeans).
- Familial clustering: linked to variants on chromosome 17 (e.g., RNF213 gene).
- Seen worldwide, including non-Asian cohorts.
⚙️ Aetiology & Pathophysiology
- Affects the distal ICA, MCA, and ACA stems.
- Results in extensive collateralisation via lenticulostriate, thalamic, and transdural anastomoses.
- Non-inflammatory; pathology shows intimal hyperplasia with lumen narrowing.
- Fragile collaterals predispose to haemorrhage.
- Similar angiographic patterns (“Moyamoya syndrome”) may occur with atherosclerosis, diabetes, or sickle cell disease.
🤝 Associations
- Haematological: Sickle cell disease, β-thalassaemia, hereditary spherocytosis, Fanconi anaemia.
- Neurological/genetic: Neurofibromatosis type 1.
- Metabolic/immune: Homocystinuria, antiphospholipid syndrome, Grave’s disease, SLE.
🩺 Clinical Presentation
- Common in children/young adults, but may present at any age.
- ⛔ Ischaemic events: recurrent hemiplegia, TIAs, cognitive impairment, silent infarcts.
- ⚡ Seizures and movement disorders (chorea, dystonia) may occur.
- 💥 Haemorrhage: intraparenchymal or intraventricular bleed from fragile collaterals.
🔍 Investigations
- 🧪 Bloods: Usually normal; confirms non-inflammatory nature.
- 🖼️ CT: Cortical/subcortical infarcts, volume loss, haemorrhage.
- 🧲 MRI/MRA: Gold standard → ICA narrowing + “puff of smoke” collaterals.
FLAIR: “Ivy sign” from slow cortical flow.
GRE: Detects microhaemorrhages in basal ganglia/thalamus.
- 📡 Transcranial Doppler: Non-invasive assessment of stenosis/hemodynamics.
- ⚡ EEG: In children → “re-build-up phenomenon” after hyperventilation.
- 🩻 Perfusion imaging: Identifies hypoperfused territories at risk of infarct.
📊 Suzuki Angiographic Stages
- 1️⃣ Early ICA stenosis.
- 2️⃣ Development of Moyamoya collaterals at brain base.
- 3️⃣ Progressive ICA occlusion; ↑ collateral vessels, ↓ MCA/ACA flow.
- 4️⃣ Circle of Willis + PCA occlusion; extracranial–intracranial collateralisation.
- 5️⃣ Fewer Moyamoya vessels; major arteries absent.
- 6️⃣ Disappearance of Moyamoya collaterals; brain perfused only by ECA branches.
⚖️ Management
- Best managed in specialist neurosurgical centres.
- 📉 Medical therapy: Limited role. BP optimisation crucial.
Antiplatelets are sometimes used in children but avoided in adults due to haemorrhage risk.
- 🧑⚕️ Surgical revascularisation:
- Direct bypass: STA–MCA anastomosis.
- Indirect: Encephaloduroarteriosynangiosis (EDAS), burr holes, encephalomyosynangiosis (EMS).
Recent studies show direct bypass reduces haemorrhagic risk most effectively.
- 💊 Aspirin often used in children; usually stopped in adults due to bleed risk.
- 📉 Most common cause of death: haemorrhage from fragile collaterals.
📖 Further Reading
💡 Exam Pearl: Moyamoya = young patient + recurrent TIAs/strokes + angiogram “puff of smoke.”
Think early referral for surgical revascularisation to prevent ischaemia and haemorrhage.